IPAD-DB ID | D01369 |
Name | Tolcapone |
Category | Drugs |
2D Structure |
|
3D Structure | |
Molecular Formula | C 1 4 H 1 1 N O 5 |
Molecular Weight | 273.24 g/mol |
IUPAC Name | (3,4-dihydroxy-5-nitrophenyl)-(4-methylphenyl)methanone |
InChI | InChI=1S/C14H11NO5/c1-8-2-4-9(5-3-8)13(17)10-6-11(15(19)20)14(18)12(16)7-10/h2-7,16,18H,1H3 |
InChIKey | MIQPIUSUKVNLNT-UHFFFAOYSA-N |
Canonical SMILES | CC1=CC=C(C=C1)C(=O)C2=CC(=C(C(=C2)O)O)[N+](=O)[O-] |
PubChem CID | 4659569 |
DrugBank Accession Number | DB00323 |
CAS Registry Number | 134308-13-7 |
Molecular Weight(Computed by SwissADME) | 273.24 |
Hac(Computed by SwissADME) | 20 |
Volume(Computed by ADMETlab 2.0) | 267.444 |
Density(Computed by ADMETlab 2.0) | 1.021 |
nRing(Computed by ADMETlab 2.0) | 2 |
MaxRing(Computed by ADMETlab 2.0) | 2 |
nHet(Computed by ADMETlab 2.0) | 6 |
fChar(Computed by ADMETlab 2.0) | 0 |
nRig(Computed by ADMETlab 2.0) | 14 |
Flexibility(Computed by ADMETlab 2.0) | 0.214 |
Stero Centers(Computed by ADMETlab 2.0) | 0 |
LogS(Computed by ADMETlab 2.0) | -3.678 |
LogD(Computed by ADMETlab 2.0) | 1.776 |
logP(Computed by ADMETlab 2.0) | 2.937 |
TPSA(Computed by SwissADME) | 103.35 |
Hbond Acceptor(Computed by SwissADME) | 5 |
Hbond Donor(Computed by SwissADME) | 2 |
Rotatable Bonds(Computed by SwissADME) | 3 |
GI Absorption(Computed by SwissADME) | High |
BBB(blood-brain barrier) Permeant(Computed by SwissADME) | No |
P-gp Substrate(Computed by SwissADME) | No |
CYP1A2 Inhibitor(Computed by SwissADME) | No |
CYP2C19 Inhibitor(Computed by SwissADME) | No |
CYP2C9 Inhibitor(Computed by SwissADME) | Yes |
CYP2D6 Inhibitor(Computed by SwissADME) | No |
CYP3A4 Inhibitor(Computed by SwissADME) | Yes |
log Kp(Skin Permeation)(Computed by SwissADME) | -5.62 |
Lipinski(Computed by SwissADME) | 0 |
Ghose(Computed by SwissADME) | 0 |
Veber(Computed by SwissADME) | 0 |
Egan(Computed by SwissADME) | 0 |
Muegge(Computed by SwissADME) | 0 |
Bioavailability Score(Computed by SwissADME) | 0.55 |